Search Results - "Goebell, P J"

Refine Results
  1. 1

    Limited survival of adult human testicular tissue as ectopic xenograft by Schlatt, S., Honaramooz, A., Ehmcke, J., Goebell, P.J., Rübben, H., Dhir, R., Dobrinski, I., Patrizio, P.

    Published in Human reproduction (Oxford) (01-02-2006)
    “…BACKGROUND: Grafting of testicular tissue into immunodeficient mice has become an interesting and promising scientific tool for the generation of gametes and…”
    Get full text
    Journal Article
  2. 2

    Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases by Fritsche, H M, Burger, M, Denzinger, S, Legal, W, Goebell, P J, Hartmann, A

    Published in The Journal of urology (01-11-2008)
    “…Urothelial carcinoma with plasmacytoid morphology is a rare and only recently described histological variant. To date only 22 cases have been published. We…”
    Get more information
    Journal Article
  3. 3

    Timing of androgen deprivation monotherapy and combined treatments in castration-sensitive and castration-resistant prostate cancer: a narrative review by Kunath, F., Goebell, P. J., Wullich, B., Sikic, D., Kahlmeyer, A.

    Published in World journal of urology (01-03-2020)
    “…Purpose Standard androgen deprivation therapy (ADT) can be initiated early at the time of diagnosis in asymptomatic castration-sensitive advanced prostate…”
    Get full text
    Journal Article
  4. 4

    Molecular Concepts of Immunomodulation for the Treatment of Metastatic Renal Cell Carcinomas: Where are We Now? by Goebell, P J, Bedke, J

    Published in Aktuelle Urologie (01-11-2015)
    “…The introduction of molecular targeted agents has started to transform the treatment of metastatic renal cell carcinoma (mRCC), leading to a significant…”
    Get more information
    Journal Article
  5. 5

    Perioperative Chemotherapy in Advanced Bladder Cancer - Part II: Adjuvant Treatment by Otto, T, Goebell, P J, Rübben, H

    Published in Onkologie (01-10-2003)
    “…Despite radical cystectomy, 40% of the patients with locally advanced disease and more than 80% of the patients with lymphatic metastases die tumor related…”
    Get more information
    Journal Article
  6. 6

    A cross-sectional investigation of fatigue in advanced renal cell carcinoma treatment: Results from the FAMOUS study by P J, Goebell, A, Münch, L, Müller, H J, Hurtz, M, Koska, S, Busies, N, Marschner

    Published in Urologic oncology (01-04-2014)
    “…Abstract Objective With an increasing choice of new treatment options, the management of side effects to maintain a chosen treatment if likely to be effective…”
    Get full text
    Journal Article
  7. 7

    Rationale Nachsorge des nicht-muskelinvasiven Harnblasenkarzinoms by von Landenberg, N., Benderska-Söder, N., Bismarck, E., Kernig, K., Erne, E., Goebell, P. J., Schmitz-Dräger, B. J.

    Published in Best practice onkologie (01-05-2022)
    “…Zusammenfassung Hintergrund Die Nachsorge des nicht-muskelinvasiven Harnblasenkarzinoms (NMIBC) stellt eine nicht abschließend gelöste Herausforderung an den…”
    Get full text
    Journal Article
  8. 8

    Surgical treatment of disseminated peritoneal metastases from urological cancer: results from a prospective study by Otto, T., Suhr, J., Krege, S., Goebell, P.J., Wishahi, M., Bier, U.W., Kimmig, R., Rübben, H.

    Published in BJU international (01-12-2002)
    “…Objective  To report a prospective phase II study of patients with disseminated peritoneal carcinomatosis and symptomatic disease, in whom the peritoneal…”
    Get full text
    Journal Article
  9. 9

    Perioperative chemotherapy in advanced bladder cancer: part I. Neoadjuvant treatment by Goebell, P J, Otto, T, Rübben, H

    Published in Onkologie (01-08-2003)
    “…Despite local tumor control, patients with locally advanced bladder cancer or lymphogenic metastasized urothelial carcinoma are at risk for systemic progress…”
    Get more information
    Journal Article
  10. 10

    p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists? by Schmitz-Dräger, B J, Goebell, P J, Ebert, T, Fradet, Y

    Published in European urology (01-12-2000)
    “…Anomalies of the p53 tumor suppressor gene have been reported for a variety of different tumor types. Also in urothelial cancer accumulation of the P53 protein…”
    Get more information
    Journal Article
  11. 11

    Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer by Chatterjee, Sunanda J, George, Ben, Goebell, Peter J, Alavi-Tafreshi, Mohammad, Shi, Shan-Rong, Fung, Yuen Kai, Jones, Peter A, Cordon-Cardo, Carlos, Datar, Ram H, Cote, Richard J

    Published in The Journal of pathology (01-07-2004)
    “…Loss of heterozygosity, mutations or deletions of the RB1 gene usually result in loss of pRb expression, which has been regarded as an indicator of loss of pRb…”
    Get full text
    Journal Article
  12. 12

    Presurgical assessments by Kahlmeyer, A, Goebell, P J, Wullich, B

    Published in Urologe. Ausgabe A (01-04-2019)
    “…For the estimation of perioperative risks and mortality in the context of radical urological tumor surgery in elderly patients, the guidelines meanwhile…”
    Get full text
    Journal Article
  13. 13

    Rational follow-up of non-muscle invasive bladder cancer by von Landenberg, N, Benderska-Söder, N, Bismarck, E, Kernig, K, Erne, E, Goebell, P J, Schmitz-Dräger, B J

    Published in Urologe. Ausgabe A (01-11-2021)
    “…Follow-up for non-muscle invasive bladder cancer (NMIBC) is a challenge for urologists that has not been finally resolved. The intensity of follow-up is based…”
    Get full text
    Journal Article
  14. 14

    Tumor cell motility as a novel target in cancer--experimental and clinical results by Otto, T, Luemmen, G, Bex, A, Suhr, J, Goebell, P J, Raz, A, Ruebben, H

    Published in Onkologie (01-04-2002)
    “…Surgery, chemotherapy and radiotherapy are the mainstay of tumor management. However, in systemic disease cure can be achieved in yet a few tumor entities…”
    Get more information
    Journal Article
  15. 15

    Follow-up of bladder cancer : The right examinations at the right time by Olbert, P, Goebell, P J, Hegele, A

    Published in Urologe. Ausgabe A (01-06-2018)
    “…Schedules for the follow-up (FU) of bladder cancer patients are predominantly based on studies with low level of evidence and the resulting guidelines'…”
    Get full text
    Journal Article
  16. 16

    Intersektorale Schnittstelle – eine Chance für Studien zur Versorgungsforschung? by Goebell, P. J.

    Published in Urologe. Ausgabe A (01-08-2020)
    “…Zusammenfassung Die Forderung nach der Ambulantisierung nimmt derzeit in der gesundheitspolitischen Diskussion einen breiten Raum ein. Somit rückt die…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20